Hirsutism in Women: Effective Therapy that is Safe for Long-Term Use

References

• Redmond GP, Bergfeld WF. Diagnostic approach to androgen disorders in women: acne, hirsutism, and alopecia. Cleve Clin J Med 1990; 57(5): 423-7
   PubMed Web of Science ®Google Scholar
• Bergfeld WF. Androgens and women’s health: androgenic alopecia. Clinician 1994; 12(3): 10-11
   Google Scholar
• McKnight E. The prevalence of “hirsutism” in young women. Lancet 1964; 41(Feb 22): 410-3
   Google Scholar
• Carmina E. Prevalence of idiopathic hirsutism. Eur J Endocrinol 1998; 139(4): 421-3
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Serrano-Gotarredona J, Garcia-Robles R, et al. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist? Metabolism 1997; 46(8): 902–7
   Google Scholar
• Martins JM, Carreiras F, Afonso A, et al. Transient hyperandrogenemia and its relation to ovulation. Fertil Steril 1998; 70(4): 664-70
   PubMed Web of Science ®Google Scholar
• Bals-Pratsch M, Hanker JP, Hellhammer DH, et al. Intermittent Cushing’s disease in hirsute women. Horm Metab Res 1996; 28(2): 105-10
   PubMed Web of Science ®Google Scholar
• Carmina E, Gentzschein E, Stanczyk FZ, et al. Substrate dependency of C19 conjugates in hirsute hyperandrogenic women and the influence of adrenal androgen. Hum Reprod 1995; 10(2): 229-303
   Web of Science ®Google Scholar
• Loughlin T, Cunningham S, Moore A, et al. Adrenal abnormalities in polycystic ovary syndrome. J Clin Endocrinol Metab 1986; 62(1): 142-7
   PubMed Web of Science ®Google Scholar
• Knochenhauer ES, Azziz R. Advances in the diagnosis and treatment of the hirsute patient. Curr Opin Obstet Gynecol 1995; 7(5): 344-50
   PubMed Web of Science ®Google Scholar
• Azziz R, Rittmaster RS, Fox LM, et al. Role of the ovary in the adrenal androgen excess of hyperandrogenic women. (Comment) Fertil Steril 1998; 70(6): 1187-9
   Google Scholar
• Rieu M, Mourrieras F, Riveline JP, et al. High serum luteinizing hormone levels induce ovarian delta4 cytochrome P450c17alpha down-regulation in hirsute women: complete effect on 17-hydroxylase and partial effect on 17,20-lyase. Eur J Endocrinol 1998; 139(3): 304-8
   PubMed Web of Science ®Google Scholar
• Lucky AW. Hormonal correlates of acne and hirsutism. Am J Med 1995; 98(1 A): 89-94S
   Google Scholar
• Rosenfield RL. Current concepts of polycystic ovary syndrome. Baillieres Clin Obstet Gynecol 1997; 11(2): 307-33
   PubMedGoogle Scholar
• Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996; 335(9): 617-23
   PubMed Web of Science ®Google Scholar
• Ehrmann DA. Insulin-lowering therapeutic modalities for polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999; 28(2): 423-38
   PubMed Web of Science ®Google Scholar
• Paoletti AM, Cagnacci A, Orru M, et al. Treatment with flu-tamide improves hyperinsulinemia in women with idiopathic hirsutism. Fertil Steril 1999; 72(3): 448-53
   PubMed Web of Science ®Google Scholar
• De Leo V, la Marca A, Ditto A, et al. Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 1999; 72(2): 282-5
   PubMed Web of Science ®Google Scholar
• Ayuk P, Stringfellow H, Donnai P, et al. Hirsutism of recent onset with marked hyperandrogenaemia and ovarian hyperthecosis after the menopause. Ann Clin Biochem 1998; 35(Pt 1): 145-8
   PubMedGoogle Scholar
• Barth JH, Jenkins M, Belchetz PE. Ovarian hyperthecosis, diabetes and hirsutism in post-menopausal women. (Comment) Clin Endocrinol (Oxf) 1997; 46(2): 129-30
   PubMed Web of Science ®Google Scholar
• Keslestimur F, Sahin Y, Ayata D, et al. The prevalence of non-classic adrenal hyperplasia due to 11 beta-hydroxylase deficiency among hirsute women in a Turkish population. Clin Endocrinol (Oxf) 1996; 45(4): 381-4
   PubMed Web of Science ®Google Scholar
• Venturoli S, Ravaioli B, Bagnoli A, et al. Contraceptive and therapeutic effectiveness of two low-dose ethinylestradiol and cyproterone acetate regimens in the treatment of hirsute patients. Eur J Contracept Reprod Health Care 1998; 3(1): 29-33
   PubMedGoogle Scholar
• Falsetti L, Rosina B, De Fusco D. Serum levels of 3alpha-androstanediol glucuronide in hirsute and non hirsute women. Eur J Endocrinol 1998; 138(4): 421-4
   PubMed Web of Science ®Google Scholar
• Young R, Sinclair R. Hirsutes. Part II: treatment. Australas J Dermatol 1998; 39(3): 151-7
   PubMedGoogle Scholar
• Redmond GP, Bergfeld WF. Treatment of androgenic disorders in women: acne, hirsutism, and alopecia. Cleve Clin J Med 1990; 57(5): 428-32
   PubMed Web of Science ®Google Scholar
• Barth JH. Investigations in the assessment and management of patients with hirsutism. Curr Opin Obstet Gynecol 1997; 9(3): 187-92
   PubMed Web of Science ®Google Scholar
• Fruzzetti F, Bersi C, Parrini D, et al. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects. Fertil Steril 1999; 7(3): 445-51
   Google Scholar
• Carmina E, Lobo RA. The addition of dexamethasone to antiandrogen therapy for hirsutism prolongs the duration of remission. Fertil Steril 1998; 69(6): 1075-9
   PubMed Web of Science ®Google Scholar
• Muderris II, Bayram F. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism. J Endocrinol Invest 1999; 22(3): 165-8
   PubMed Web of Science ®Google Scholar
• Wheeland RG. Laser-assisted hair removal. Dermatol Clin 1997; 15(3): 469-77
   PubMed Web of Science ®Google Scholar
• Crave JC, Fimbel S, Lejeune H, et al. Effects of diet and met-formin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 1995; 80(7): 2057-62
   PubMed Web of Science ®Google Scholar
• Elkind-Hirsch KE, Anania C, Mack M, et al. Combination go-nadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism. Fertil Steril 1995; 63(5): 970-8
   PubMed Web of Science ®Google Scholar
• Erenus M, Yucelten D, Durmusoglu F, et al. Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism. Fertil Steril 1997; 68(6): 1000-3
   PubMed Web of Science ®Google Scholar
• Bertoli A, Fusco A, Magnani A, et al. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism. Exp Clin Endocrinol Diabetes 1995; 103(1): 15-20
   PubMed Web of Science ®Google Scholar
• Erenus M, Yucelten D, Gurbuz O, et al. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism. Fertil Steril 1996; 66(2): 216-9
   PubMed Web of Science ®Google Scholar
• Rittmaster RS. Antiandrogen treatment of polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999; 28(2): 409-21
   PubMed Web of Science ®Google Scholar
• Kelestimur F, Sahin Y. Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism. Fertil Steril 1998; 69(1): 66-9
   PubMed Web of Science ®Google Scholar
• Yucelten D, Erenus M, Gurbuz O, et al. Recurrence rate of hirsutism after 3 different antiandrogen therapies. J Am Acad Dermatol 1999; 41(1): 64-8
   PubMed Web of Science ®Google Scholar
• Isik AZ, Gokmen O, Zeyneloglu HB, et al. Low dose ketoconazole is an effective and relatively safe alternative in the treatment of hirsutism. Aust N Z J Obstet Gynaecol 1996; 36(4): 487-9
   PubMed Web of Science ®Google Scholar
• Lissak A, Sorokin Y, Calderon I, et al. Treatment of hirsutism with cimetidine: a prospective randomized controlled trial. Fertil Steril 1989; 51(2): 247-50
   PubMed Web of Science ®Google Scholar